Mike Russell

Johnson & Johnson Co. - New Jersey / United States

Medical and Health Sciences / Medical Oncology

AD Scientific Index ID: 4387727

-

Registration, Add Profile,
Premium Membership

Print Your Certificate

Mike Russell's MOST POPULAR ARTICLES

1-) Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastomaJA Rader, MR Russell, LS Hart, MS Nakazawa, LT Belcastro, D Martinez, ...Clinical cancer research 19 (22), 6173-6182, 20133922013

2-) RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastomaKA Cole, J Huggins, M Laquaglia, CE Hulderman, MR Russell, K Bosse, ...Proceedings of the National Academy of Sciences 108 (8), 3336-3341, 20112762011

3-) CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locusMR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ...Cancer research 75 (15), 3155-3166, 20151552015

4-) Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastomaMR Russell, K Levin, JA Rader, L Belcastro, Y Li, D Martinez, B Pawel, ...Cancer research 73 (2), 776-784, 20131462013

5-) Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine featuresQ Liu, MR Russell, K Shahriari, DL Jernigan, MI Lioni, FU Garcia, ...Cancer research 73 (11), 3297-3305, 20131372013

ARTICLES

Add your articles